OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

L-carnitine Modulates Cognitive Impairment Induced by Doxorubicin and Cyclophosphamide in Rats; Insights to Oxidative Stress, Inflammation, Synaptic Plasticity, Liver/brain, and Kidney/brain Axes
Olivia Fayez Morid, Esther T. Menze, Mariane G. Tadros, et al.
Journal of Neuroimmune Pharmacology (2023) Vol. 18, Iss. 3, pp. 310-326
Open Access | Times Cited: 16

Showing 16 citing articles:

Interaction effect of crocin and citalopram on memory and locomotor activity in rats: an insight into BDNF and synaptophysin levels in the hippocampus
Samineh Nasseri, Shadi Hajrasouliha, Salar Vaseghi, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 9, pp. 6879-6888
Closed Access | Times Cited: 7

Kidney-brain axis in the pathogenesis of cognitive impairment
Qianqian Yan, Mengyuan Liu, Yiling Xie, et al.
Neurobiology of Disease (2024) Vol. 200, pp. 106626-106626
Open Access | Times Cited: 6

Phytochemical profiling and neuroprotective activity of Callistemon subulatus leaves against cyclophosphamide-induced chemobrain
Omyma Rabie, Heba A. S. El‐Nashar, Mina Y. George, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115596-115596
Open Access | Times Cited: 14

Lycopene mitigates paclitaxel-induced cognitive impairment in mice; Insights into Nrf2/HO-1, NF-κB/NLRP3, and GRP-78/ATF-6 axes
Nasriah Zakaria, Esther T. Menze, Doaa A. Elsherbiny, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111262-111262
Closed Access

Neuromodulatory effect of troxerutin against doxorubicin and cyclophosphamide-induced cognitive impairment in rats: Potential crosstalk between gut–brain and NLRP3 inflammasome axes
Nada K. Gamal, Reem N. El‐Naga, Iriny M. Ayoub, et al.
International Immunopharmacology (2025) Vol. 149, pp. 114216-114216
Closed Access

Comprehensive review of the expanding roles of the carnitine pool in metabolic physiology: beyond fatty acid oxidation
Feng Xiang, Zhimin Zhang, Jingchen Xie, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access

Roflumilast attenuates doxorubicin and cyclophosphamide combination-induced chemobrain in rats through modulation of NLRP3/ASC/caspase-1/GSDMD axis
Georgette Eskander, Sherihan G. AbdelHamid, Sara A. Wahdan, et al.
Life Sciences (2025) Vol. 362, pp. 123378-123378
Closed Access

Protective effects of L-carnitine against Beta-amyloid-induced memory impairment and anxiety-like behavior in a rat model of Alzheimer's disease
Yekta Jahedi Tork, Erfan Naseri, Hamid Shokati Basir, et al.
European Journal of Pharmacology (2024) Vol. 982, pp. 176879-176879
Closed Access | Times Cited: 2

Trace elements and metal nanoparticles: mechanistic approaches to mitigating chemotherapy-induced toxicity—a review of literature evidence
Ademola C. Famurewa, Mina Y. George, Cletus Anes Ukwubile, et al.
BioMetals (2024) Vol. 37, Iss. 6, pp. 1325-1378
Closed Access | Times Cited: 1

Mechanisms and Protective Strategies in Cognitive Impairment Induced by Combination of Doxorubicin and Cyclophosphamide
Nada K. Gamal, Reem N. El‐Naga, Mina Y. George
Archives of Pharmaceutical Sciences Ain Shams University (2024) Vol. 8, Iss. 1, pp. 109-121
Open Access

Melatonin Mitigates Doxorubicin Induced Chemo Brain in a Rat Model in a NRF2/p53–SIRT1 Dependent Pathway
Neven A. Ebrahim, Mohamed R. Elnagar, Randa El-Gamal, et al.
Heliyon (2024) Vol. 10, Iss. 19, pp. e38081-e38081
Open Access

Enhancing radioprotection: exploring the impact of L-carnitine supplementation on the oxidative stress in the liver
Funda YILDIRIM BAŞ, Halil Aşçı, Mehmet Abdulkadir Sevük, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access

The effect of L-carnitine in reactive oxygen species reduction and apoptotic gene expression in mice after cyclophosphamide: An experimental study
Majid Almasi, Golnaz Shafiei, Hossein Nikzad, et al.
International Journal of Reproductive BioMedicine (IJRM) (2024)
Open Access

Neurodegenerative biomarkers and inflammation in patients with propionic and methylmalonic acidemias: effect of L-carnitine treatment
Bianca Gomes dos Reis, Graziela S. Ribas, Desirèe Padilha Marchetti, et al.
Metabolic Brain Disease (2024) Vol. 40, Iss. 1
Closed Access

Diagnostic and Treatment Approaches to Chemo Brain
Fatma Gül Helvacı Çelik, Meltem Puşuroğlu, Sefanur Köse, et al.
Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry (2024) Vol. 17, Iss. 2, pp. 301-322
Open Access

Silymarin Nanoparticles Counteract Cognitive Impairment Induced by Doxorubicin and Cyclophosphamide in Rats; Insights into Mitochondrial Dysfunction and Nrf2/HO-1 Axis
Fatma G Aboelnasr, Mina Y. George, Maha Nasr, et al.
European Journal of Pharmacology (2024), pp. 177217-177217
Closed Access

Page 1

Scroll to top